rs750146811
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000285071.9(FLCN):c.235_238del(p.Ser79ThrfsTer50) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000205 in 1,461,796 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S79S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000285071.9 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLCN | NM_144997.7 | c.235_238del | p.Ser79ThrfsTer50 | frameshift_variant | 4/14 | ENST00000285071.9 | NP_659434.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLCN | ENST00000285071.9 | c.235_238del | p.Ser79ThrfsTer50 | frameshift_variant | 4/14 | 1 | NM_144997.7 | ENSP00000285071 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 251030Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135748
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461796Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727198
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Feb 06, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 19, 2022 | PP1, PP4, PM2, PS4_moderate, PVS1 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 27, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27780965, 29357828, 24430303, 19116017, 23223565, 15657874, 19802896, 21937013, 19562744, 33726816, 35176117) - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 11, 2023 | The FLCN c.235_238del; p.Ser79ThrfsTer50 variant (rs750146811) is reported in the literature to segregate with bullous lung lesions and pneumothorax in a large family (Painter 2005). This variant is reported in ClinVar (Variation ID: 3371) and is found in the non-Finnish European population with an allele frequency of 0.0012% (3/251030 alleles) in the Genome Aggregation Database. Based on available information, this variant is considered to be pathogenic. References: Painter JN et al. A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet. 2005 Mar;76(3):522-7. PMID: 15657874 - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Feb 16, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics and Genomics, Karolinska University Hospital | May 28, 2014 | - - |
Birt-Hogg-Dube syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jul 18, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2023 | This sequence change creates a premature translational stop signal (p.Ser79Thrfs*50) in the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). This variant is present in population databases (rs750146811, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with bullous lung lesions and pneumothorax (PMID: 15657874). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3371). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Jan 18, 2023 | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. - |
Familial spontaneous pneumothorax Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2009 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 08, 2023 | The c.235_238delTCGG pathogenic mutation, located in coding exon 1 of the FLCN gene, results from a deletion of 4 nucleotides between positions 235 and 238, causing a translational frameshift with a predicted alternate stop codon (p.S79Tfs*50). This mutation, designated as c.733delTCGG, was first reported as strongly segregating with an isolated primary spontaneous pneumothorax (PSP) phenotype in a large Finnish family (Painter JN et al. Am. J. Hum. Genet. 2005; 76:522-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at